In a recent editorial, Callen1 reviewed 6 articles concerning lupus erythematosus (LE). We are compelled to respond to his rhetorical question “is TLE [tumid LE] a misnomer?”1(p318) Callen contends that TLE should not be included within the LE spectrum because “the skin lesions in these patients do not scar or cause atrophy,”1(p318) and “they are not characterized by an interface dermatitis.”1(p318) Furthermore, he says “[TLE] does not belong among the cutaneous lesions observed in SLE [systemic LE].”1(p318) We will address each of these points sequentially.